Fungal Disease Clinical Trials

8 recruitingLast updated: July 25, 2026

There are 8 actively recruiting fungal disease clinical trials across 5 countries. Studies span Phase 1. Top locations include Tianjin, Tianjin Municipality, China, Beijing, Beijing Municipality, China, Chengdu, Sichuan, China. Updated daily from ClinicalTrials.gov.


Fungal Disease Trials at a Glance

8 actively recruiting trials for fungal disease are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Tianjin, Beijing, and Chengdu. Lead sponsors running fungal disease studies include Institute of Hematology & Blood Diseases Hospital, China, Azienda Ospedaliero-Universitaria Careggi, and Assistance Publique - Hôpitaux de Paris.

Browse fungal disease trials by phase

About Fungal Disease Clinical Trials

Looking for clinical trials for Fungal Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fungal Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fungal Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score

PneumoniaFungal InfectionPneumocystis Pneumonia+7 more
Azienda Ospedaliero-Universitaria Careggi400 enrolled1 locationNCT07681583
Recruiting

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Invasive Fungal DiseaseAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Peking University People's Hospital6,000 enrolled1 locationNCT07569055
Recruiting

A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis

Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China38 enrolled1 locationNCT07357038
Recruiting

Immunomonitoring of Mold Invasive Infections

Invasive Fungal DiseaseMold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT06285188
Recruiting

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases

Invasive Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China36 enrolled1 locationNCT07135778
Recruiting

Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

Invasive Fungal Disease
Sichuan Provincial People's Hospital1,000 enrolled1 locationNCT06819410
Recruiting

FungiScope - A Global Emerging Fungal Infection Registry

Invasive Fungal Disease
University of Cologne1,000 enrolled1 locationNCT01731353
Recruiting
Phase 1

Fungus-specific immune cells for bone marrow transplant patients with invasive fungal disease

Invasive Fungal Disease
Western Sydney Local Health District20 enrolled4 locationsACTRN12618001540202